Silk science for advanced regeneration
Unlocking the potential of biomedical silk protein in soft tissue regeneration
Sofregen provides medical practitioners with natural biomaterials to enhance their surgical artistry and achieve more durable results for their patients.
Tops News & Media Coverage
Galderma Announces Exclusive Agreement With Sofregen to Develop the Next Generation of Biostimulator Fillers Using Silk-Based Technology
PENTAX Medical Enters Into An Exclusive Distribution Agreement With Sofregen For Novel Silk Voice Injectable
Soft Tissue Engineering Biotechnology Company Sofregen Raises $8 Million in Series B Funding Round
Sofregen Receives 510(k) Clearance for Silk Voice® – The First and Only Natural Silk Protein Injectable Product for Tissue Bulking